| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |